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Medical Staff
Progress Notes
From the
-11 President

The world hates change,
yet it is the only thing that
has brought progress.
Charles F. Kettering

There are those who would suggest
that the only thing that changes faster
than the Spring weather in New
England is the medical climate in
America today. It's been some time
now since we, as a medical staff, have
enjoyed the "Golden Era" of medicine
'
if we ever did. We are immersed in a
cultural revolution of legal and
insurance oversight, increasing
expectations, manpower plans, and
hospital affiliations.
Well, we_here_~!.~ehigh Valley
Hospital..are.aboutto undergo amajor change. As you know, on-Wednesday, ·
August 6, 1997, the Board of Trustees
of Lehigh Valley Hospital and
Muhlenberg Hospital Center
announced their intentions to merge
the two institutions. While this
merger will have very significant
positive effects with regards both to
providing better integrated health

~em'f
~:=:.~:

systems and programs to the
Allentown and Bethlehem
communities and to improving the
merged institutional financial base and
credit rating, this action is bound to
raise serious concerns on the parts of
members ofboth medical staffs. The
medical staff leadership at both
Muhlenberg Hospital Center and
Lehigh Valley Hospital realize that
there are some very significant issues
facing us in this new Lehigh Valley
Hospital Health Network. These
concerns have caused us to defer any
immediate merging of the two medical
staffs. Instead, we plan to take on
these issues prior to any attempt at
merging staffs. I ask that members of
the Lehigh Valley Hospital medical
staff communicate your concerns and
hopes to a member of the Medical
Executive Committee, Troika, or
myself so we can continue to repres, ,.. t
you responsibly at the negotiation
table.
It also appears that the nature of
PennCARE will be changing slightly
An a way in which the .effect it will
have on the medical staff at Lehigh
Valley Hospital is unclear. Abington
Hospital has applied for membership
in PennCARE and the PennCARE
Board has accepted their application.
Obviously, this means that Lehigh
Valley Hospital will no longer be the
only medical community able to
provide tertiary care to PennCARE
(Continued on Page 2)

..

(Continued from Page 1)

subscribers. This will necessitate that
our staff be able to be better at
"COOPITITION'' than our Abington
colleagues. While we must cooperate
to insure the integrity of the Integrated
Delivery System which helps protect
us from the competition in
Philadelphia, atAllegheny, at
Columbia/HCA and others, we must
be able to be better at providing the
absolute finest care in a financially
responsible manner so as to insure that
the obvious choice for medical care
will most certainly be the physicians
on this medical staff.
So too, as in any climate of change,
some prefer to change climates. I
would be remiss if I did not publicly
recognize colleagues and friends who
will be leaving Allentown to begin
practice elsewhere. To Larry
Feldman, Paul Guillard, John Samies,
and David Vargas, thank you for all
you have done for the people of the
Lehigh Valley during your tenure here
and thank you for all·the help and
support you provided to me.

On a more uplifting note, however, WP
as a medical staff should celebrate anL
recognize the recent U.S. News &
World Report which ranked the
geriatrics and urology programs at
Lehigh Valley Hospital as among the
nation's finest. While, on a more local
level, we recognize the tremendous
talent embodied in the staff here, it is
gratifying to see our brethren
recognized on a national level as well.
Congratulations to Fran Salerno and
Ed Mullin and all the members of your
respective divisions!
Finally, as a reminder, our next
General Medical Staff meeting will be
held on Monday, September 8, at 5:30
p.m., in the auditorium at Cedar Crest
& I-78. I look forward to seeing all of
you there!
President, Medical Staff

)

Robert X. Murphy, Jr., MD

At-Large Member Needed for Medical Executive Committee
Due to the recent resignation of John
H. Samies, MD, from the Medical
..Executive.:...Committee, ~e~ Medical._
StaffNoftll.nating-Committeeis~~··- ..
seekiri.g.noiriinations· to"fillthe ·vacant
seat with the term ending June 30,
1999. The election will be held at the
General Medical Staff meeting on
September 8. Nominations will be
accepted from the floor at the meeting.

If you have any questions regarding
this issue, please contact David M.
Caccese, MD, Chairman of the

Nominating Committee, or John W.
Hart, Vice President, at 402-8980.

-·~·================~·
.....Jbere~willbe.a.meeting of the General
Medical Staff on Monday, September 8,
beginning at 5:30p.m., in the Auditorium at
Cedar Crest &1-78. All members of the
Medical Staff are encouraged to attend.
Immediately following the meeting, a
reception will be held in honor of the
Divisions of Geriatrics and Urology which
were recently ranked among the nation's
finest as published in U.S. News & World
Report.
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Semi-Annual Needs Survey
)

By now, you should have received a
memo dated August 15, 1997, which
marks the beginning of the SemiAnnual Needs Survey for the Medical
Staff as called for in the Hospital Staff
Development Plan. The purpose of
these surveys is to reView the clinical
specialtY needs of the Hospital.
Under the Hospital Staff Development
Plan, requests for slots in the Active
and Associate categories must be
made via the semi-annual needs
survey. You may document any need
for additional personpower (in your
group, division, or other department)
by completing the Hospital Staff
Development Specification Statement,
which is available in the office of
Medical Staff Services at Cedar Crest
& 1-78.

)

)

Your completed request form must be
received in the office of Medical Staff
Services at Cedar Crest & 1-78 NO
LATER THAN SEPTEMBER 14,
1997 in order that it may be included
in this semi-annual needs survey
.which will result in the Board of
Trustees taking action on these
requests for slots at the January 7,
1998 meeting.
As part of the process, it is required
that you discuss your request with the
____::.Dep~ep.t Chairp_~<?n, obtaining hi~
· signature (on the Hospital :Staff
DevelOpment Specification Statement)
to indicate that the discussion took
place, prior to the September 14
deadline. Your request will later be
reviewed by the appropriate
Department Chairperson in
consultation with the Division and
Section Chiefbefore being presented
to the Hospital Staff Development

Advisory Committee, the Performance
Improvement/Staff Development
Committee of the Board of Trustees,
and the Board of Trustees. The
Department Chairperson will acquire
input concerning all slot requests in a
manner determined by each
department and the Staff Development
Plan.
Please be reminded that all Active
and Associate staff appointments, at
Lehigh Valley Hospital, where there·
exist no presently approved slots, will
require processing in this manner.
If you have any questions regarding
this process, please contact either John
W. Hart, Vice President, or Beth
Martin, Executive Secretary, at
402-8980.

Attention Physicians and
Office Managers
Medical Staff dues letters will be
distributed shortly. Timely
remittance of dues is both
requested and appreciated.

· A General Membership meeting of ·
the Greater -Lehigh Valley
Independent Practice
Association, Inc~, will be held on
Tuesday, September 23, at 6 p.m.,
in the Auditorium at
Cedar Crest &I·78.
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L VH Ranks Again on America's Best Hospitals List
Lehigh Valley Hospital ranked as one
of the top providers in the nation for
geriatrics and urology in U.S. News &
World Report's eighth annual guide to
"America's Best Hospitals."

Part of that is the Vitality Plus
program for people 50 and older.
Members receive benefits of health
and education programs, hospital
amenities, social events and discounts.

Geriatrics was ranked for the second
year in a row and is the only hospital
in Pennsylvania, outside of
Philadelphia and Pittsburgh, to be
recognized for care of elderly people.
This was the first year LVH's urology
program was ranked.

Urology has 10 board-certified .
physicians who run a continence
program for women and an oncology
program. The division is also involved
in Prostate Awareness Week, a
program held each September that
offers free prostate cancer screenings.

According to magazine officials, the
top 42 medical centers in any specialty
should be considered a leading center.

Currently, the Division of Urology is
working to implement brachytherapy,
implantation of radioactive seeds in
the prostate to treat prostate cancer,
and a continence program for men,
said Edward M. Mullin, Jr., MD,
Chief, Division ofUrology. The
program was ranked 27.

The geriatrics program at LVH was
introduced in 1990 by Francis A.
Salerno, MD. The Division of
Geriatrics provides educational
programs, clinical services, research
and community outreach. More than
30 of the hospital's doctors are
certified in geriatrics, but the program
really involves all ofthe staff at LVH.
Geriatrics was ranked 41.

"We have one of the busiest urology
services in the country, which we were
not aware of,'' Dr. Mullin said. "While
all the members felt we were
practicing a high quality of urology as
well as a high volume, the Division of
"I feel we still have a great deal of ·
Urology is certainly gratified by the
work to do and there are a number of
official and public recognition of its
activities being planned and
efforts and proud of its performance.
implemented,'~ Dr. Salerno said. "We
We have a good group of doctors that
aspire to be in the top 10 next year."
work hard for excellence in patient
care."
- "~One'ofthe most -sucoessftd geiiatrics
- - ·.,. ' ··pregra.m&46-the-~atric . ______ --~Accor.ding..to U.S. ..News & World
Evaluation Service (AGES). Geriatric
Report, this year's "America's Best
specialists evaluate the patient's
Hospitals" lists assessed care for 17
medical, functional, psychological,
specialties at 135 hospitals
social and economic needs and then
nationwide. Rankings for 13 of the
recommend treatment options, living
specialties were based on reputation
arrangements and community agencies
and various medical data. The
to provide assistance and family
hospital was evaluated on its
support. The goal is to help the patient
reputation, mortality rate, service mi1
remain independent as long as
possible.
(Continued on Page 5)
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)

(Continued from Page 4)

)

and technology. Those specialties
included: AIDS, cancer, cardiology,
endocrinology, gastroenterology,
geriatrics, gynecology~ neurology,
orthopedics, otolaryngology;
pulmonary disease, rheumatology and
urology. Rankings in ophthalmology,
· pediattics, psychiatry and
rehabilitation were based on reputation
alone.

To be considered for ranking, a
hospital had to be a member of the
Council of Teaching Hospitals
(COTH), or be affiliated with a
medical school, or have a score of 10
or more on a scale of available
hospital technology. This year, 1,800
hospitals were evaluated.

Colleagues:
After 25 years of leading the clinical research mission in Allentown, Dr. David
Prager is stepping down as Senior Investigator for the Eastern Cooperative
Oncology Group (ECOG) and Principal Investigator for the National Surgical
Adjuvant Breast and Bowel Project (NSABP) at Lehigh Valley Hospital.

)

Widely recognized as establishing the practice of medical oncology and
hematology in Allentown, Dr. Prager has been instrumental in guiding first the
Allentown Hospital, and more recently, the Lehigh Valley Hospital through the
development oftheir cancer program. In particular, he was the medical director
of the cancer program when the John and Dorothy Morgan Cancer Center was
completed in 1993.
I will succeed Dr. Prager as the new ECOG senior investigator, and Herbert C.
Hoover, Jr., MD, will succeed him as principal investigator ofNSABP. Dr. Prager
will continue as an active member in both groups and will continue to participate
in their clinical trials program.
I want to acknowledge David's contribution to the cancer program at Lehigh
Valley Hospital. The patients and families ofAllentown owe him a significant debt
for his role in establishing the high quality ofoncologic practice in this
_ communitY._~ In addition, through David's ECOG and NSABP leadership, both
.''"/ihysidansand patients"haveparticipafed"iiiadvancing the outcomes ofcancer
- ··treatmenHhrough·theirparticipatiorrin-clinictJl-trials. · ··
Chuck Hoover and I are looking forward to continuing the tradition of clinical
investigation started by Dr. Prager. We plan to expand the clinical research
mission further through our academic collaboration with Penn State University
Cancer Center at Hershey and our clinical affiliation with the Johns Hopkins
Oncology Center.

)

Gregory R. Harper, MD, PhD
Director, Morgan Cancer Center
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Abington Memorial Hospital Joins Penn CARE
Abington Memorial Hospital has
joined the- PennCARE integrated
health care delivery system, bringing
the number ofhospitals to 11
employing 13,000 people, with
. _combined medical staffs of3,000
physicians. More than 3.7 million
residents live in the counties now
served by PennCARE providers, an
area measuring 5,400 square mile.s.
This new addition makes PennCARE
the largest health care network in
Pennsylvania from the standpoint of
beds (2,528), inpatient admissions per
year (112,000), and emergency
department visits per year (315,000).
Abington Memorial Hospital is a
regional acute care hospital with 508
licensed beds and a medical staff of
more than 600 physicians and 3,500
employees, providing medical care
and health services to residents in
Bucks, Montgomery, and Philadelphia
counties. The hospital has the only
Level II accredited trauma center in
Montgomery County, and offers
highly specialized services in cancer
care, maternal-child health, and
cardiac care. Last year, the hospital
had more than 21,000 inpatient
admissions and 436,000 outpatient
visits.
··-·-·- · ""Ournew"PenneAREl'mtners add- -~--tremeBdously~o -th.e-bre8dtb..and.depth -~
of medical care available to the people
of eastern Pennsylvania through a
single, integrated network," said Elliot
J. Sussman, MD, Chairman of the
Board and President ofPennCARE.
''They share the vision of other local
health care systems in PennCARE,
that local health care decision making
through a provider-led network is the
best way to care for our communities."

Other partners in PennCARE include
)
the following hospitals and
participating members of their medical
staffs: Doylestown Hospital; Easton
Hospital; Gnaden Huetten Memorial
Hospital in Lehighton; Grand View
Hospital, Sellersville; Hazleton
General Hospital; Hazleton-St. Joseph
Medical Center; Lehigh Valley
Hospital; Muhlenberg Hospital
Center; North Penn Hospital,
Lansdale; and Pocono Medical Center,
East Stroudsburg.
The PennCARE network was
introduced in May 1995 and began
contracting with managed care
companies in August 1996.
The PennCARE network does not
involve the merger of assets; each
member remains independent and has
agreed to participate in mutual
)
contracting, consistent medical
management and single data collection
to measure and improve health
outcomes of individuals covered under
its health plans.

Patient Death Notification
If a patient dies, it is the attending
physician's responsibility to notify the
·iamily. -·lf1here·is another attending
..physician .from another faciUty (i.e.,
Allentown State Hospital) who referred
the patient to Lehigh Valley Hospital, AS
A COURTESY, the attending physician at
Lehigh Valley Hospital should contact the
attending physician at the referring facility
regarding the patient's death.
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JCAHO Reminders
)

Restraints/Seclusion
Sixty percent of all hospitals surveyed
thus far in 1997 have received a Type
1 recommendation during the survey.
-· . -. (A Type l recommendation··recognizes
a serious deficiency in the hospital's
processes and affects accreditation
status.) Your help will prevent us
from being added to that number.

)

Remember:
• A new order must be written every
24 hours after a face-to-face
assessment by the physician
(physician order sheets are
available).
• Documentation supporting the
continued use of the
restraint/seclusion must be found
in the progress notes.
• The order must contain the
following: Date/Time, Type of
Restraint, Purpose for Restraint,
Criteria for Discontinuation,
Length of Time for Restraint
(additional requirements for
Psychiatry/Behavioral Health
Patients include RN' s ability to
reassess for continued use of
restraint/seclusion).
• TelephoneNerbal Orders must be
co-signed within 24 hours.
. ,J.CAHQ_sllzyeyors will look for
.::- ·-complianoe-with the..above4aring .
· their reView of operi-and closed
medical records and in the interview
sessions.

Reminders:
• All sample medications must enter
through the pharmacy (the
specifics needed will be logged in
according to policy).
• When medication samples are
dispensed, all necessary
information must be documented
on the sample dispensing log
sheets (required in case of a recall
or follow-up).

Medical Records
Patient confidentiality must be
maintained at all times.
Remember:
• To follow policy in regards to
medical record security.

Outpatient Services
Lehigh Valley Hospital at Cedar
Crest & 1-78 provides a designated
location for outpatient services
related to diagnostic imaging and
outpatient laboratory work. The
services are provided in the 1230
medical office building in Suite 104
and 102, respectively. In order to
serve our patients more effectively
·and ,efficiently, please communicate
· this information to your patients to
assure that they arrive at the right
location for their testing.

Medicadons

)

Our process for controlling sample
medications will be looked at closely.
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Reminders and Notes from Transfusion Service
Blood Transfusion and
Hepatitis Notification
When blood transfusion is implicated
as a cause of Hepatitis, the
···Transfusion Service needsto be
notifiea in order to convey this
information to the regional blood
collecting facilities so that the donor
of the unit is identified as potentially
infectious and deferred from further
blood donations. To notify the
Transfusion Service, please call the
Blood Bank at 402-8181.

HCVTesting
Recently, the American Liver
Foundation has recommended
(through advertisements in the press)
that persons who have received blood
transfusions prior to May, 1990 be
tested for HCV. These individuals are
being identified as high risk for
developing chronic liver disease. .
The first generation HCV test was
approved by FDA in May, 1990, and
most blood centers had started testing
the donor blood immediately.
Cirrrently, a second generation test for
HCV is available. This has eliminated
a large number of false positive tests
seen with the first generation test. To
. dat~A/AABB o~,.CDC have not
·issued-any fonnal-guidetines on this .
issue~--We are closely monitoring this
and will immediately relay any
information that becomes available to
us. In the meantime, it is
recommended that if you have any
such patient in your practice, that you
give serious consideration to obtaining
a HCV test on these patients. The test
is performed on the serum, and can be
ordered individually or as part of a
Hepatitis profile.

The risk of acquiring transfusion
associated HCV is 1:100,000. The
risk of acquiring transfusion
associated HBV is 1:60,000.

Maximum Surgical Blood
Ordering Schedule (MSBOS)
As you may know, the MSBOS went
into effect on August 1, 1997. The
Transfusion Service will make a
monthly report to the Transfusion
Committee as to the effectiveness of
this process. This is a performance
improvement (PI) indicator to meet
JCAHO expectations. Since the
MSBOS was presented at most
individual division meetings prior to
finalizing the program, it is hoped that
everyone will be an active participant
in this PI. If you have any questions
or concerns regarding the schedule,
please e-mail or call Bala B. Carver,
MD, Director, Transfusion Service, at
402-8142.

)

Price Increase in RhiG
(RhoGam)
The companies that manufacture this
product are anticipating a marked
increase in the pricing due to a FDA
mandated purification step to
eliminate any possible infection
.potential. The manufacturers deeply
r~gret this increase, but feel they have
no choice in the matter but to comply
with the FPA mandate. The expected
increase is fourfold over the current
pncmg.
Medical Staff Trivia
According to Medical Staff Services records,
60 members of the Medical Staff are married
to another doctor on the Medical Staff.
PageS
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Neonatal Resuscitation
)

Just a reminder that all physicians,
nurse midwives, and nurse
practitioners who attend deliveries are
required to be up-to-date on this
certification.
·-

For your convenience, Neonatal
Resuscitation recertification!
certification will be held during the
month of September. This will be
your ONLY opportunity to recertify/
certify for 1997 and 1998 -- if you
expire in 1998, make sure that you
attend.
The dates and times are as follow:
•

•

)

Friday, September 5, at 7 p.m.
through Monday, September 8, at
?a.m.
Friday, September 12, at 7 p.m.
through Monday, September 15, at
?a.m.

Bristol-Myer~

)

•

Thursday, September 18, at 11
a.m. through Friday, September
19, at 3 p.m.
• Thursday, September 25, at 11
a.m. through Friday, September
26,at 3p.m.
All sessions will be held in the "old"
ICU area at 17th & Chew. Take the
blue elevator to the 4th floor and turn
right.
If you must perform intubation,
neonatology may or may not be
available during the time that you
recertify/certify. Please call to check
availability. For more information or
if you have any questions, please
contact Wendy Am.ig, Perinatal
Patient Care Specialist, at 402-3895 or
beeper 5100-9769.

Blood Pressure Study

Individuals are currently being
recruited for a Phase IT 14-week drug
dosing blood pressure study. The
drug, BMS-186716, is a potent
metalloprotease inhibitor to be utilized
as a once-a-day antihypertensive
agent. This project is being
supervised by-Nelscm.P... Kopyt, DO,
and Gina M. Karess, MD, at 17th·&
Chew. Th~--Clinical Research·· ·
Specialist is Marianne Y. Benioff, RN,
BSN. All participants will receive
free medications, exams and testing.
Enrollment is open until the end of
September 1997. The project is to be
completed by January 1998. Criteria
for the study protocol are as follows:

1. Age 18 or older

2. Male or female (must be surgically
sterilized or post-menopausal)
3. Hx of mild to moderate HTN
(SeDBP 95-11 OmmHg).
For additional information, contact
,,Marianne .Benioffat 402-9524.
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Library News
OVID Training

.

To schedule a one-on-one OVID
(MEDLINE) training session, call
Barbara lobst in the Health Sciences
Library at Cedar Crest& I-78 at
402-8408.

Library Construction - Cedar
Crest & 1-78
Construction will begin in the near
future for the Meyer Cohan Learning
Resource Center (LRC). The LRC
(virtual classroom) is designed to be a
multipurpose, multimedia classroom
for the delivery of medical education.
It is anticipated that the construction
will take about 2 1/2 months.

New Additions to the Library
Collection
The following books were recently
acquired by the Cedar Crest & 1-78
Library:

AJCC Cancer Staging Manual, 5th
edition
Author: American Joint Committee
on Cancer
Call No. QZ 241 A312 1997
(Reference Section)
,...-.•.,J..

···-:::.,~·-...:.:·:.:;·"'C1HTelltTherapy in-Eadocrinology· -- · ~
.: ~ ...:~::-.:.: ... and.Metabollsm, 6th ~tipn · ·_=...___
Author: C. Wayne Bardin
Call No. WK. 100 B235c 1997

Disease Management: A Systems
Approach to Improving Patient
Outcomes
Author: Warren Todd, et al.
Call No. W 84.7 06111996

Guide to Clinical Resource
Management
Author: Mickey Parsons, et al.
Call No. W 74 G945 1996
Publications purchased for the 17th &
Chew Library include:

Clinical Gynecologic Oncology, Sth
edition
Author: Philip DiSaia, et al.
Call No. WP 145 D611c 1997
Clinical Obstetrics and Gynecology
Volume 40, Number 2- June 1997
Topic: "Managed Care and the
Obstetrician/Gynecologist''
Guest Editor: Arnold Cohen
The Fragile Alliance: An
Orientation to the Psychiatric
Treatment of the Adolescent, 4th
edition
Author: John Meeks
Call No. WS 463 M494f

)

Breaking Free of Managed Care: A
Step-By-Step Guide to Regaining
Control of Your Practice
(Behavioral Health)
Author: Dana Ackley
Call No. W 80 A182b 1997
Rheumatology in Primary Care
Author: Juan Canoso
· ·Call No. ·WB:544.C227r 1997

)
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Congratulations!
)

Deborah N. Kimmel, MD, Division of
Physical Medicine/Rehabilitation;
Alexander D. Rae-Grant, MD, Medical
Director, Neurodiagnostic Lab; Sharon
Bartz, Staff Assistant; Kathleen Bodnar,
RN; Nancy J. Eckert, RN, Clinical
- ·ResearchSpecialist; and John Graham,
BS, CSCS, Director, Human Performance
Center, have become members of the
Consortium of Multiple Sclerosis
Centers. The Consortium ofMultiple
Sclerosis Centers comprises centers from

all around the world dedicated to
education, advocacy, and research, and
new management strategies of
management of multiple sclerosis.
Sophia C. Kladias, DMD, Division of
General Dentistry, received the Academy
of General Dentistry's prestigious
Fellowship award during the convocation
ceremony at the Academy's 45th annual
meeting held in Chicago, Til., on August

2.

Papers, Publications and Presentations

)

George A. Arangio, MD, Section of
Orthopedic Trauma, had two articles
published iri. recent months -"Biomechanical Study of Stress in the
Fifth Metatarsal" in the March, 1997
issue of Clinical Biomechanics, and
"Reemployment ofPatients with Surgical
Salvage of Open, High-Energy Tibial
Fractures: An Outcome Study" in the
May, 1997 issue of the Journal of
Trauma.
Peter A. Keblish, Jr., MD, Chief,
Division of Orthopedic Surgery, was an
invited member of the guest faculty of
Summer University at the University of
Edinburgh at Scotland UK in June. The
Summer University, held under the
direction of the faculty of the University
and Mr. Peter Abernathy, is designed to
treat specialized subjects for the newly
_..
-graduated..orthopedic -r.egistrar.s in the UK
---····1md-other comrtriesin Europe. The · UniversitY-is fashioned after the Suniiner
Institute held in the United States, under
the direction of the American Academy
of Orthopaedic Surgeons.

)

Dr. Keblish was involved in moderating
and directing case study groups as well as
presenting formal lectures and
demonstrations. He presented several
topics on subjects including surgical
approaches, techniques and experience

with primary and revision total knee
replacement.
Dominic P. Lu, DDS, Program Director,
Dentistry Residency, had excerpts from
his study, "Clinical Comparison of
Various Intramuscular Sedation Agents
and their Reversal Drugs" published in
Vol. 25, No. 1, 1997 of Pain Control.
Michael Sheinberg, MD, Division of
Primary Obstetrics and Gynecology, coauthored a research paper, "Application
ofTelethermography in the Evaluation of
Preterm Premature Rupture of the Fetal
Membranes," which was published in
Volume 30, Number 6, November/
December 1996, of Biomedical
Instrumentation & Technology.
Michael Weinstock, MD, Chairperson,
. .Department .of Emergency Medicine, will
· ··provide·the Keynote Address-- Our
Specialty, Ourselves: Where We Stand-at the 4th Annual Emergency Medicine/
Emergency Medical Services
Convergence to be held at the Split Rock
Resort in Lake Harmony from September
19-21. In addition, Dr. Weinstock will be
one of the program presenters for New
Frontiers in Acute Stroke Management, to
be held on Saturday, September 20, from
11 a.m. to 1 p.m.
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Upcomi~g Seminars,

Conferences and Meetings

Medical Grand Rounds
Medical Grand Rounds are held every
Tuesday from noon to 1 p.m., in the
hospital's Auditorium at Cedar Crest
& 1-78.
Topics to be discussed in September
include:
September 2 - Infectious Disease
September 9 - Rheumatology

September 16 - Department of·
Medicine
September 23 - Geriatrics
September 30 - Endocrinology
For more information, please contact
Becky Sherman in the Department of .
Medicine at 402-8200.

Who's New
The Who's New section of Medical
Staff Progress Notes contains an
update of new appointments, address
changes, status changes, etc. Please
remember to update your directory and
rolodexes with this information.

Medical Staff
Change ofPractice Affiliation
Kenneth G. Ryder, Jr., MD
(no longer with Shepherd Hills Family
Practice)
(Opening solo practice September 2)
4955 Route 873, Suite B
P.O. Box388
SchnecksVille, PA 18078-2211
(610) 799-4100
~:· FAX:'\61"0)799-410~~

·..

--

Change ofAddress
Michael L. Zager, MD
(Lehigh Internal Medicine Associates)
East Penn Family Practice
1040 Chestnut Street
Emmaus, PA 18049-1998
(610) 967-4830
FAX: (610) 965-7737

As our second class of residents starts,
the Family Practice Residency will have
a much more active inpatient teaching
service which will include adults,
children, and birthing.
In order to assist hospital staff, a
coverage schedule of days, nights, and
weekends has been distributed to all
clinical care units.

)

We ask that our charts be identified as
"FPS" (for Family Practice Service) in
addition to identification of the
attending, e.g., "White/FPS".
For our physician colleagues, we ask
that you follow hospital guidelines for
consultation and teaching when
assisting .in the care of our patients.
We are looking forward to developing
productive, educational, and patientcare relationships with you.
Brian Stella, MD
Department of Family Practtce

)
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HEALTH NETWORK
)

LABORATORIE.S
A Service of

lEHWVAILEY
HOSPITAL

International Cytology Conference
Hawaii, USA· June 5 to 10, 1997

).
'

The International Academy of Cytology organized, for
the first time in its history, an international conference
on Diagnostic Cytology Towards the 21st Century.
This conference was held on the big island of Hawaii
from June 5 to 10, 1997. It was entirely different
from many previous lAC meetings, tutorials, and
world congresses in cytopathology. · It dealt
predominantly with selected topics prepared in
advance and comprising 11 task forces. Their prime
goal was to lay the foundations for future diagnostic
cytology practice in the 21st century. The 11 task
force topics were as follows:
•

•
•
•
•
•
•
•
•
•

)

•

Atypical squamous cells of undetermined
significance (ASCUS) and atypical glandular
cells of undetermined significance (AGUS)
criteria.
Human papilloma virus (HPV) and cervical
precancer, screening frequency, and HPV
testing.
Telecytology.
Terminology.
Quality assurance and,quality controlisstJes. ::":" ,. _
Computerized screenir19 de~ices.
Cost/benefit assessments of automated devices.
Cell preparation methods and sample adequacy
criteria.
Colposcopy, endoscopy, cervicography,
speculoscopy. .
Medical/legal implications of automated
prescreening.
Automation in cytology education and proficiency
testing.

Each task force was chaired by an individual of most
prominent experience and contributions to the body
of diagnostic cytology literature. In addition, there
were three to four co-chairs who had the function of
helping the chairman with his obligations. Varying
numbers of contributors submitted short
commentaries on particular areas of interest or
experience within the subject matter of each topic
forwarding their comments (about three pages single
spaced) to the Chicago conference office. The
collated and duplicated contributions were then
forwarded to the chairs and co-chairs from Chicago.
It was the job of the chairs and co-chairs to consider
the submitted material for possible entry into the
position papers. The chairs, in cooperation with their
co-chairs, prepared preliminary position papers for
eventual presentation at the conference, sending a
hard copy and a floppy disk, to the Chicago
· conference office for reproduction and insertion into a
three-ring binder. It was only then that the Chicago
office prepared the material for insertion into the
- three-ring binder which contained the final position
__ papers and all contributions submitted by the task
·. ··:·for~-members.-1>uring the cooference, which took
- -,_ place betweerfJtlne 6 and·'1u; an·taskiorce
members and every conference registrant had the
opportunity to participate in the actual deliberations.
The questions and/or comments will appear in the
printed version of the Task Force Proceedings in
August. Thus, all position papers, including the
contributions, would be prepared for publication. The
contributors will have the opportunity to amplify
and/or modify their manuscripts before materials go
to press. Acta Cytologica will devote the entire
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January/February 1998 issue to the achieved
consensus as well as topics of significant interest to
gynecologists which will appear in the Journal of
Reproductive Medicine.
·
There were five conference lectures of outstanding
interest and important medical/scientific data for the
benefit of all participants in this international
conference. On Friday, June 6, the first conference
lecture submitted by Harubumi·Kato, MD, PhD, FIAC,
Tokyo, Japan, was on Cytologic Findings in Early
Central Type Lung Cancer and Their Endoscopic
Appearances. The same day, a second conference
lecture was given by Shiro Nozawa, MD, PhD, MIAC,
Tokyo, Japan, on Novel Enzyme Immunoassay for
Endometrial Cancer using cytologic specimens. On
Saturday, June 7, a conference lecture by Yoshio
Tenjin, MD, PhD, FIAC, and Tadashi Sugishita, MD,
FIAC, Tokyo, Japan, was on New Approaches to the
Evolution of Diagnostic Cytology, focusing on the
correlation between cell morphology and genetic
changes. On Sunday, June 8, the conference lecture
by Professor Nils Stormby, MD, PhD, FIAC, of
Malmo, Sweden, was on Clinical Cytology, a
Valuable Diagnostic Tool in a Tight Health Economy.
Finally, the last conference lecture by Mark A.
Shiffman, MD, MPh, and Diane Solomon, MD, MIAC,
National Cancer Institute, NIH, Bethesda, Md., was
on The Comparison of Cervical Cancer
Methodologies.

Finally, a word on the choice of the venue of this
important international conference. The site of
Hawaii was not selected, in my opinion, for this work
intensive and trend setting conference only to
facilitate access from Pacific rim countries. It truly
projected an image of an intensely awe inspiring
venue by virtue of its unique attractive
geologic/volcanic makeup compelling all to realize
that one could not escape feeling close to the
.creation of planet Earth.
Harry Z. Suprun, MD, FIAC
Department of Pathology
Division of Cytopathology
Lehigh Valley Pathology Associates
Lehigh Valley Hospital

David G. Beckwith, PhD, Vice President,
Network Laboratory Services, and Clinical
Director, Health Network Laboratories, was
recently the keynote speaker at the St. Louis
Chapter of the Clinical Laboratory
Management Association and participated in
two Edu-trak sessions on laboratory
management and laboratory automation at the
annual meeting of the American Association of
Clinical Chemistry in Atlanta, Ga.

)

Although each task force was supposed to deal
primarily with its specific subject matter, it became
quite evident during the deliberations and
discussions that many of the participants had
justifiably made quite numerous incursions into
neighboring fields of other specific subject matters.
The impression gained was that all task forces were
united by a common'thread·of-interdisciplinaty · .
structural relationships. Throughout-the-entire · . . .
conference, this outstanding feature was particularly
noticeable during the presentation of the various
position papers and the discussions that emanated
thereof.

)
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DRUG INFORMATION BULLETIN
Pharmacy Department- July, 1997 Editors: Maria Barr, Pharm.D.,BCPS, Howard Cook, R.Ph., BCNSP, FASHP .
Barbara Leri, Pharm.D., Rebecca Hockman, Pharm.D.
'
The following ~ormation was distributed.to the housestaff in July, 1997. As a means of communication with the
Attending PhySicians, the Drug Information:Bulletin is being reprinted. PI~ _review the information and contact
the pharmacy .if any questions arise.
..,.,..
....

PHARMACY WELCOME TO THE
NEW HOUSE STAFF
Our Phannacy staff would like to extend a
sincere welcome to the new house staff. Our
department provides a comprehensive service
to patients, physicians, and staff as an integral
part of the patient care, teaching, and research
programs. This newsletter is a part of that
service, and our goal is to keep you informed
of recent activities of the Therapeutics
Committee and the Food and Drug
Administration.

)

Each year a few issues commonly require
clarification by the Phannacy Department.
Please take note of the following:

PHARMACY AT THE POINT OF
SERVICE!
Pharmacists are no longer confmed to the
basement! Unit Based Pharmacy Services
have been instituted house wide since the
initiation of Patient Centered Care. Every
weekday from 0730-1600 and until 2200 on
floors 4-7, pharmacists are unit based to
perform order entry for his/her assigned area
as well as various clinical functions.

)

Clinical 'functions ofour ~pharmacy staff
include activities such as proyidiiJ.g drug
information, drug dosage adjustments,
pharmacokinetics, alternative therapy options,
IV-PO conversions, and patient teaching. The
Unit Based Pharmacist is an indispensable
resource to assist you throughout your day.
Cellular phone nwnbers and beeper nwnbers
are listed in the newsletter for your
information. Pharmacist phone/pager numbers
can also be found posted on patient care areas.

Do not hesitate to contact a unit based
pharmacist or the main pharmacy with
questions at any time.
The Pharmacy Department houses a wide
variety of journals and texts to answer drug
related questions. Also, the Micromedex
system, a computerized CD-ROM based
clinical information system containing features
such as Drugdex, Indentidex, Poisondex, and
Emergendex is available on the hospital
network to all pharmacists and physicians.

THE HOSPITAL FORMULARY
The Lehigh Valley Hospital Formulary is
developed under the auspices of the
Therapeutics Committee which acts as an
advisory group to the Medical Staff concerning
drugs and their usage. The Hospital Formulary
serves as a teaching aid, as well as a guide and
standard for prescribing drugs. The formulary
is available in a binder format on all nursing
units. Each version is arranged in six parts:
Part I- Formulary Information and Procedures
Part II - Fomiulary Drugs by Category
·
Part. ill - Formulary Generic Drug List
Part IV- Section unused at this time
Part V - Appendices
Part VI - Parenteral Nutrition Order
- ____ _ Guidelmes
.,- -·
Part VID ""<·Physician's Assistant-Formulary
7

Please note some of the useful tables and
charts that are available in the appendices:
- Medication Administration Times
- Adverse Reaction Reporting System and
Reporting Form
:.. Antacid, Vitamin Comparison Chart
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- Narcotic Analgesics Comparison/
Conversion
- Standard Diluent, Volume and Infusion
Rate Schedule
- Medication Stop Order Policy
- Therapeutic Equivalent Substitution List

DEA NUMBERS .
Temporary DBA numbers may be assigned to
the new residents upon request of the
residency directors. The Pharmacy assigns
each resident's temporary DBA number, but
each specific department (i.e. Medicine,
Surgery, Family Practice, OB/GYN, ED, and
Dentistry) must relay this information to the
resident. Please note the temporary D EA
number for all residents is the site's Pharmacy
DBA number plus a unique three digit suffix.
Each resident will have two separate DBA
numbers one for use at Cedar Crest & 1-78
and one for use at 17th & Chew.

A list of the standardized or premixed
continuous infusions can be found in Appendix
XIV. Some of these include Heparin 25,000
units/250ml, Insulin 50 units/lOOml, Morphine
100mg/100ml and Theophylline 800mg/250ml.

..CURRENT.RECOMMENDATIONS
·FOR VENOUS
THROMBOEMBOLISM (VTEIDVT)
Orthopedic (hip and
knee replacement):

warfarin

General Surgery:

unfractionated heparin
plus sequential
compression devices
(SCD)

Trauma Surgery:

warfarin and/or low
molecular weight
heparin (*only for high
risk patients defined by
VTE protocol) until
able to take warfarin
and SCD.

PRESCRIPTIONS
Residents may obtain prescriptions from
Health Spectrum Pharmacy at cost plus a
dispensing fee for him/herself and dependent
relatives. The prescription will need to be paid
for at time the medication received.
Prescriptions are not filled by the inpatient
pharmacy department.

Hematology/Oncology: warfarin

STANDARD/PREMIXED IVS

Other Uses
lnterventional
Cardiology:

Drugs with standardized diluent, volume and
infusion rate (when applicable) are listed in
Formulary Appendix X. When ordering any of
these drugs, please write only the dosage,
route and frequency on the order sheet.
Include diluent and/or volume only if it is
medically Il!=~ss;u:y ancL~Y\te it .as such on the__ ..
physician's order. For example, writing
Cefazolin lOrn1V -Q8H-issttfficient -to order · ---~
this dose. The cefazolin will be dispensed in a
syringe with an appropriate volume of diluent
(lOml of sterile water for injection) and the
rate of infusion will be dependent on volume
in the syringe. The diluent needs to be
indicated only if mandated by patient's clinical
condition. (i.e. patient is fluid restricted).

OB/GYN:

)

unfractionated heparin

unfractionated heparin
and current thombotic
regimens (Poor
literature support for
use of LMWH post
intervention).

-*'Note-that presently, low molecular weight
heparin (formulary: enoxoparin (Lovenox)
30mg SQ Q12H) is restricted to high risk
trauma patients. In the rare instance that a
patient must receive enoxaparin due to
difficulty in blood draws to monitor INR's for
warfarin adjustment, it must be clearly noted
on the order.

)
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HEPARIN DOSING
)

A preprinted weight-based heparin order sheet
is available for use for all patients requiring
continuous infusions of heparin. The heparin
dose should be based on total body weight for
both the bolus and maintenance dose. There
are scales for the aPTT on the order sheet to
address dosing .adjustments ofheparin. A -_
pocket guide for weight-based heparin is
available for review for use of parenteral
heparin.

TPA

)

There are specific guidelines used in dosing
TPA. Preprinted order sets can be found in the
Emergency Departments and Coronary Care
Units for its use for Acute MI. The order sets
include all the available thrombolytic agents
with strategies for Acute MI. Please note the
weight dosing parameters for patients weighing
less than 65Kg found in the guidelines. Due to
the urgency required in ordering TPA, it
would be helpful for the physician to call the
pharmacy IV room (ext. 8879) directly or have
the order brought to pharmacy to expedite the
compounding and delivery of this medication
for the patient. A written order indicating the
patient's weight and desired dose must be
received prior to dispensing. The pharmacy
department will deliver the thrombolytic agent
to patient care areas.
TPA may also be used for acute ischemic
stroke (initiated 0-3 hours after symptom
onset) and in acute pulmonary embolism. The
protocols follow.
Acute ischemic stroke:
0.9mg/Kg (total dose_.=:;_ 90mg)
--io%- dosew bofUS- - - :_ .
Remaining 90% I111l""''Yer-6e-minutesq
Acute pulmonary embolism:
1OOmg give over 2 hours
(not weight dosed)

ELECTROLYTE DOSING
)

KCL
The Therapeutics Committee (5/93) approved

the following rate and concentration
parameters for potassium administration.
1.

Peripheral I:.ine for All Units (nonmonitored and monitored patients);

IY·Infusion: 20mEqlhr (2.0mEq/1 OOml with
80mEqlbag .limit)
IV Bolus: 20mEqlhr (20mEq/100ml with
20mEqlbag limit)
2.

Central Line Limits- Non-Monitored
Patients:

IV Infusion: 20mEqlhr (40mEq/100ml with
80mEqlbag limit)
IV Bolus: 20mEqlhr (lmEq/1ml with
40mEqlbag limit)
3.

Central Line Limits - Monitored
Patients:

IV Infusion: 40mEqlhr (1mEq/100ml with
80mEqlbag limit)
Maximum Daily Doses: 300mEq per
24 hour period

4.

* To reduce the risk of phlebitis, it is ·
recommended that sterile water be utilized as
the diluent, especially when concentrations
exceed 1OmEq/lOOml
* All solutions with a concentration greater
than 1mEq/10nil must be administered via an
electronic rate controlling device regardless of
{}el~ery ~ite. .. ,._____ _
WHEN TO USE SUSTAINED-RELEASE
KCL
The sustained-release (SR) or time-release(TR)
form is preferable for patients who need KCl
supplements chronically. Immediate-release
products, such as the KCl elixir and the
intravenous form, are indicated when
hypokalemic patients need immediate
~-----
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potassium replacement. Physicians, therefore,
should request KCl elixir to be given for an
oral stat or now order. The best way to order
any medications is to write the generic name,
suffix with SR only if sustained-release form is
desired. The following examples are
illustrations Qf the types of orders desirable
when requesting an .oral KCl dose: ----

Physician Order/

Pharmacy Dispenses
(Per Dose)

KC140mEq po stat/now- KC140mEq elixir
-K-Dur 20mEq tab
KCl SR 20mEq po
KCl 20mEq via NGT -K-Dur 20mEq*
* Aqueous K-Dur suspension maintains SR
property (Not for STAT/NOW USE),
Recommended that 1 tablet be dissolved (NOT
CRUSHED) in 4oz water, allow 2-3 minutes
to disintegrate.
Calcium
IV
Calcium Gluconate
dose:0.5-2gm (5-20ml);
rate..$.. 5ml/min (500mg/min; 2.5mEq/min)
eguivalents: One 10%ml/amp = 1gm Calcium
gluconate = 4.6mEq Ca.= 93mg Ca
Calcium Chloride
dose: 0.5-1gm (5-10ml);
rate..$.. 1ml/min (100mg/min; 1.5mEq/min)
eguivalents: One 10% m1 syringe = 1gm
CaC12 = 13.6mEq Ca = 272mg Ca
Magnesium
Standard IV bolus:
for serum Mg 1.6-2.0mg/dl:

8mEq .Mag··Sulfl5emt-D5W. -- ( = 1gmfMag Su_lf,giv_en over lfz hr ·
for serum mMg < 1.6mg/dl:
16mEq Mag Sulf/100ml DSW
( =2gm) Mag Sulf given over 1 hr

Oral equivalents:
Magnesium Chloride (slow-mag) time released
1 tablet = 535mg MgC1 2
= 64mg Mg
= 5.4 mEq Mg+ +

)

Magnesium Gluconate
_ 1 tablet = SQOm.g Mg glucenate
= 27 mg Mg.
= 2.25 mEq Mg+ +
5mlliquid = 1OOOmg Mg gluconate
= 54mgMg
= 4.5 mEq Mg++
Phosphorus
Potassium Phosphate: lml contains
4.4 mEq K+
3 mM phosphate
Sodium Phosphate: 1ml contains
4 mEq Na+
3 mM phosphate
IV Infusion: usual dose 15-30 mM
phosphate/liter over 6-8 hours
for serum P 1.0-2.0mg/dl:
15 mM ( < 7mM/hr)
for serum P< l.Omg/dl:
30mM

)

*The highest dose reported is 0.125mM/Kglhr
(rate..$.. 7 mMihr) for 4 hours. The dose is
recommended only for patients with normal
renal function noted to have initial serum
phosphorus concentration < 0.5mg/dl.
Recheck the serum phosphorus concentration
at the end of the infusion.

PARENTERAL ANTIBIOTIC
ORDER SHEETS·(PAOSJ
Lehigh V-aHey- Hospital utilizes~ separate and
unique physicians order sheet for parenteral
antibiotics. This order sheet allows the
physician to choose preferred formulary
antibiotics, their dosage and usual frequency

)
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)

(assuming normal renal function) . .There is
also space available to order additional tests
such as antibiotic levels or cultures. These
sheets should be used for all parenteral _
antibiotics, including pre-op doses. A Pediatric
P AOS is also available on units with pediatric
patients.
Please complete the patient allergy and
reaction section at the top of the sheet.
If an antibiotic does not appear preprinted on
the order sheet, it may be written on the
bottom of the PAOS. This section is available
for reserVed antibiotics which need special
monitoring for drug utilization processing. The
order sheet should be completely filled out
with suspected pathogen and site (if empiric
therapy) as well as special instructions, if
needed.

)

There are suggested usage guidelines on the
back of PAOS for general pathogenic coverage
for antibiotics. Refer to these guidelines for
empiric therapy, if cultures and sensitivities
are not available. Please attempt to tailor or
narrow empiric antibiotic therapy once culture
· and sensitivity results return. Lehigh Valley
Hospital's antibiogram, updated annually, is
found in the parenteral antibiotics section of
the patient chart.

Augmentin
250mg TID ($4.74/day)
(amox/clavulanate)
500mg TID ($7.08/day)

ONCE DAILY AMINOGLYCOSIDE
DOSING
Patients prescribed ge~tamicin or tobramycin
should be considered for one~ daily dosing
unless excluded by the criteria stated below.
1.
Patient neutropenic (ANC < 1000)
2.
Suspected or documented treatment of
endocarditis
3.
Patient has cystic fibrosis, cirrhosis,
ascites, or myasthenia gravis
4.
Pregnant or nursing mothers
5.
Patients on dialysis or ARF patients
6.
Aminoglycoside used for synergy for
staph or enterococcal infection
7.
Patients with history of drug-induced
ototoxicity
8.
Special considerations
a) amputee
b) one kidney
c) concomitant nephrotoxic drugs
Detennination of Dose
a)
Calculate CrCI
b)
Detennine dosing weight
1)
Use total body weight (TBW)
if not obese ( > 20% over

mw)

For obese patients take 40% of
excess weight add to mw
c)
Dose based on weight + CrCl
The Ph~cy Department strongly encourages
1) ~ 50ml/min ·
5mg/Kg/Q24H
conversion to oral antibiotic therapy as soon as
2) 30-49ml/min
5mg/Kg/Q36H
clinical conditions pennit. Listed below are
3) 20-29ml/min
5mg/Kg/Q48H
some common conversions.
4) < 20ml/min
2mg/Kg x1
Monitor____ . _
·-- --- . _,_,~~- --,-.,-:-'"-'-::-.;.._ Pb - · · il) · -..oetain ·SCr Q2-3--days
Ciproflox.aGin ..
500mgQ12H ($5.60/day)·--- - ""' - **b) '"'Obtam-ro\NDOMlevel 6:;;8 "hours
200mgQ12H ($26.00/day)
750mgQ12H ($9.52/day)
prior to next dose after initiation of
400mgQ12H ($50.00/day)
therapy.
Clindamycin
*Please note: Once daily dosing does NOT
600mgQ8H ($4.86/day)
150mgQ6H ($2.64/day)
require traditional peak.and trough levels.
900mgQ8H ($6.60/day)
c) If le~el < 1.0 mg/dl continue therapy,
obtam level q 5 days. If level
Cefazolin
Cephalexin
> 1.0 mg/dl and < 3, increase
1GmQ8h ($3.00/day)
500mgQ6-8H ($0.56/day)
interval by 12 hours.

IV-> PO ANTIBIOTIC
CONVERSIONS

)

Unasyn
1.5gmQ6H ($22.00/day)
(ampicillin/SB)
3.0gmQ6H ($41.60/day)

2)
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d)

Monitor fluid status, cardiac function,
cultures and sensitivities.

HELP CONTROL RESISTANT
ENTEROCOCCUS
Prescribers are urged to consider the following
guidelines for all use of vancomycin to
decrease the possibility ef emergence of
vancomycin-resistant S. aureus and/or -s.
epidermidis.

CDC guidelines for Vancomycin use:
1.
Treatment of documented or
suspected** serious infections with a
resistant gram positive organism (i.e.
methicillin resistant Staph aureusMRSA, or methicillin resistant Staph
epidermidis-MRSE).
2.
Treatment of a staphlstrep or other
gram positive infection in patients with
serious allergy to penicillin or
cephalosporin (described as hives
and/or respiratory distress and/or
collapse within minutes of a dosage
of a penicillin or cephalosporin):
OR, if history of the reaction is
unobtainable.
3.
PO vancomycin for antibioticassociated enterocolitis (due to
c.difficile colitis) which has failed to
respond to metronidazole OR is severe
and potentially life threatenfug.

4.

5.

Use as surgical prophylaxis in patients
with a serious allergy to penicillin .QI
cephalosporin (described as hives
and/or respiratory distress and/or
collapse wi!hin minutes of a dosage of
Ji~enicillln ·ar ceph31osporin): OR. if-·
·history of the-reactiorr is unobtainable. ·
Endocarditis prophylaxis as outlined by
the American Heart Association for
penicillin or cephalosporin allergic
patients.

NON-FORMULARY DRUGS
If an order is written for a non-formulary ·
drug, the pharmacy will provide an alternative

via an automatic substitution list. If a
substitution is not available the physician will
be contacted with a recommendation of a
formulary equivalent or alternative, if possible.
If no equivalent is available and the medication
is medically necessary, it will be obtained and
dispensed as soon as it is available. The
acquisition Qf the non-formulary item may be
delayed ·by > 24 hours since the medication
will need to be ordered from an outside
pharmacy or wholesaler. If a non-formulary
drug is brought by the patient from home, the
pharmacy will dispense the patient's supply of
the medication to the nursing unit upon receipt
of a complete physician's order stating,
"patient may use own medication. " The
complete name of the non-formulary
medication, strength, route and frequency must
be indicated. The pharmacy will not dispense
any formulary items brought from home by
patients.

PARENTERAL NUTRITION
ORDERS
Lehigh Valley Hospital has a separate
parenteral nutrition order sheet which includes
complete ingredient listings for the available
standard total parenteral nutrition (TPN) and
standard peripheral parenteral nutrition (PPN)
solutions, available in 1 and 2 liter bags.
·These standard solutions can be ordered at any
time. Customized solutions can be ordered as
well, if required. All parenteral nutrition is
prepared for a 24 hour period of time.

)

All parenteral nutrition orders MUST be
received in the main pharmacy by 1500, to
allow for adequate preparation time for the
solutions to be hung at 2100. Late orders will
. _NOT be honored after fSOO. These late orders
wiil-be·'COOSidered ·as -parenteral nutrition
orders for the following day. The ordering
physician will be notified by a pharmacist if
this delay will occur.
All new parenteral nutrition orders and any
changes to an already existing parenteral
nutrition order require a completely rewritten
parenteral nutrition order. Also a completely

)
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)

rewritten order is required every 7 days to
assure that a current active order is in the
patient's chart at all times, even if the chart is
broken down. Parenteral nutrition solution
orders are valid for a 48 hour period of time.
Following 48 hours, the physician may reorder
the same solution on a regular blue physicians
order sheet by ~riting "SAME TPN",
"RENEW TPN ... ·or ..a similar .statement if no·
changes to the parenteral solution are required.
If the required 48 hour renewal (as above) or a
completely rewritten parenteral nutrition order
is not received by 1500, Dextrose 10% will be
hung in its place.

INJECTABLE MULTIVITAMIN
SHORTAGE

)

There is currently a national shortage of adult
parenteral multivitamin formulations, created
by the discontinuation of one manufacturer's
product and the exhaustion of the current
equivalent product, Astra's MVI-12.
Currently, LVH has adopted the following
guidelines, based on suggested treatment
options provided by the American Society of
Parenteral and Enteral Nutrition:
1.

2.

3.

)

Use oral multivitamin supplementation
whenever possible. Oral liquid
formulations are available for those
patients with feeding tubes.
Preferential use of parenteral
multivitamins for all parenteral
nutrition patients. This group will
receive multivitamin infusion on
Tuesday, Thursday, Saturday and
Sunday while supply lasts, or until the
shortage subsides.
For all otl,l~r parenteral multivitamin
.~requestS (and wh.eii~current parenteral
nutrition ·muitivitamin·stores ·are
exhausted), the pharmacy has been
approved by the Therapeutics
Committee to automatically substitute
the following:
Folic Acid 1mg injection
Cyanocobalamin 100mcg
injection
Thiamine 100mg injection

This policy will continue until the current
shortage has ended. It should be noted that
injectable ascorbic acid is also available for
use, as indicated.

ALBUMIN SHORTAGE
Currently, there is an indefinite shortage of
.5% .and 25% .albumin. · The most common
reason for use of 5% albumin· is to increase BP
or urine output postoperatively once the patient
has been given as adequate fluid challenge
with a crystalloid such as NSS or lactated
ringers. After the patient has received usually
a maximum of 2 L of crystalloid the physician
may tum to a colloid for effect, since colloids
remain in intravascular space and decrease risk
of fluid overload leading to peripheral and
pulmonary edema.
25% albumin is used to maintain or increase
oncotic pressure when a patient's serum
albumin is < 2gm/dl, with large weepy
wounds, or to maintain cerebral perfusion
pressure in patients with subarachnoid
hemorrhage and pancreatitis.
Hetastarch 6% 500ml should be recommended
as a alternative for 5% albumin 250 or 500ml
in the following situations:
. 1.

Platelet count is > 50k, since there is
a caution with the use of Hetastarch
with thrombocytopenia.

2.

Normal renal failure. If patient still
has any renal function, hetastarch can
be used.
No severe bleeding disorders, such as
ITP, etc.
<Nora>CNS (head injury_patient).
Hetastar.ch can cause ..an increase in
ICP's.

3.
4.

Usual adult dose of Hetastarch (500ml
Hetastarch = 500ml 5% Albumin): 30-60gm
(500-1000ml)) Hetastarch over 1-2 hours.
Usual daily dose = 20mg/kg/day to a
maximum of 1500ml/day. Slight lab
jlbnormalities have been seen with platelet
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function, PT and PTT, not associated with an
increase in clinical bleeding, with volumes of
> 1500ml/day.

monitor effects. The patient may only require
250ml to achieve the desired outcome and this
would help preserve our presently low stock.

In severe renal impairment (est. CrCl <
10ml/min), use the same initial dose but
subsequent doses should be reduced by 2550%.

A concerted effort by all staff will assist the
hospital in reserving our present supply for our
critically ill patients who truly need Albumin
therapy;

Hetastarch Precautions and Contraindications
include:

ANTINEOPLASTIC ORDER SHEET

1.
2.

3.

4.

Caution in patients with
thrombocytopenia.
Caution with patients with a history of
liver disease with underlying elevated
bilirubin.
Contraindication for the management
of cerebral vasospasm associated with
subarachnoid hemorrhage.
Contraindication in patients with
severe bleeding disorders, renal failure
with oliguria or anuria.

Hetastarch Adverse Effects include:
1.
Increased SED rate.
2.
May interfere with platelet function
and cause transient prolongation of PT,
PTT and clotting times.
3.
May slightly decrease platelet/
hemoglobin concentrations due to
dilutions.
4.
May increase serum amylase but is not
associated with pancreatitis.
For your information, the hospital costs for
colloids are as follows:
Albumin 5% 500ml
$90.00
Albumin 5% 250ml
$45.00
Albumin"25% -lOOmt.
$90.00
$45.00
Albumitl25% 50ml."'_
Hetastarch 6% 500ml
$31.00
Please limit your prescribing of Albumin 5%
whenever possible. ·If patients truly necessitate
Albumin 5% administration, please indicate
the reason for use on the order to avoid having
the pharmacist calling the prescriber. If
possible, attempt to use lower volumes, such
as 250ml vs 500ml Albumin for first line and

)

An order sheet addressing chemotherapy, fluid
replacement, and pre and post antiemetic
therapies is available. The sheet includes
details regarding the patient's necessary
demographics, laboratory vascular access, and
investigational protocol information. The
order sheets are available on 6C, the oncology
unit.

IV DILTIAZEM CRITERIA
FOR USE
IV Diltiazem was added to the Lehigh Valley
Hospital Formulary for use in SVT as a
second-line agent to IV Verapamil.

)

IV Diltiazem intermittent boluses and/or
continuous infusion may be administered after
meeting at least one of the following criteria:
1.

Failure of I. V. verapamil.

Failure defined as inadequate HR control after
a total cumulative IVP verapamil dose of 20mg
followed by a continuous infusion of verapamil
1Omg/br x 1 hour.

2.

And/or Intolerance to a Smg I. V.
verapamil dose defined as:
..a.
A decrease _in systolic blood
pressure..of 10mmHg from
baseline or-<·90mmHg and
OR
symptomatic.
b.
New onset or worsening CHF
signs and symptoms.
c.
Documented allergy to
Verapamil Hcl.

3.

Baseline symptomatic hypotension <
90mmHg requiring pressor agents or,

)
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EF S. 35% and/or PCWP.L_
20mrnHg.

)
4.

I. V. Diltiazeni will not be used as a
p.o.substitute in NPO patients.

• ORDERS MUST STATE REASON FOR
USE ON THE .PHYSICIAN'S ORDER ...
SHEET BEFORE THE DRUG CAN .BE
DISPENSED.
IF A REASON IS NOT GIVEN, THE
PHYSICIAN WILL BE CALLED TO
CLARIFY THE ORDER ACCORDING TO
THE THERAPEUTICS COMMITTEE
APPROVED CRITERIA.
Usual Verapamil dosing: 5-lOmg N bolus
over at least 2 minutes followed by a
continuous infusion of 5mg/hr. Dose titration
to control ventricular rate below 100 beats per
minute should be done q15-30 minutes at 2.55mg increments.

)

ALTERNATIVES TO SUBLINGUAL
NIFEDIPINE
Based on recent literature addressing the risks
of the sublingual "bite and chew" route of
immediate release nifedipine for acute .
hypertension, the Therapeutics Committee
developed the following adult hypertension
algorithm. (see attaclunent)

ADVERSE DRUG REACTION (ADR)
REPORTING
The standards for the Medical Staff an
Pharmaceutical Services established by the
Joint Commission for the Accreditation of
Healthcare Organizations ..(J~O) encourages ..
hospitals to report -adverse reactions io all food
and drugs adininisieroo to patients.
event . '·""".
of an adverse drug reaction, either suspected
or documented, an ADR form should be
completed. A copy of the ADR form can be
found in the formulary in Section 5, Appendix
n. The ADR forms are available on all nursing
units for your use. Please complete and return
forms to the Pharmacy Department. The ADR
information can assist the staff in identifying

-rn- an

)

trends or patterns of ADR's that require
further investigation, provide information
necessary for making formulary
decisions and recommend new drug
administration guidelines and find topics for
drug use review.
'I:hrough combined effqrts of our house staff
and hospital personnel the ADR reporting
system can help to improve overall patient
care.

DRUG REPRESENTATIVE POLICY
Lehigh Valley Hospital has recently
strengthened its policy regarding
pharmaceutical company representatives.
Representatives may meet with physicians,
nurses, pharmacists, etc. by appointment only.
Representatives are not permitted to interrupt
staff members in the halls, on nursing units, in
the cafeteria, etc. All visits require a
previously scheduled appointment. The policy
has been implemented in an attempt to
maintain better control of formulary items as
well to contain rising costs of medications.
Your cooperation with the hospital policy is
appreciated. Please refer to your individual
departments for more information.

PHYSICIAN ORDER SHEET
CHANGE
As of July 1, 1997 it will be necessary for
physicians to specify " "brand necessary"
in order for a brand drug to be dispensed.
This is a change from LVH's previous policy
which authorized brand drug dispensing when
the drug was simply underlined on the order
sheet which led to confusion.
-.Howev.er.,..the.old order .sheets which read,
"authorization is hereby given to -dispense the
generic or chemical equivalent unless
specifically underlined by the physician" will
remain in circulation until the supply is
exhausted. New forms will read,
"authorization is hereby given to dispense the
generic or chemical equivalent unless specified
as brand necessarv by the physician.
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GENERAL AND CUNICAL PHARMACY SERVICE
Location
Cedar Crest & 1-78

Service

Unit Based Pharmacy Services
MICU/SICU/STU
ACU/PCU/3C/BU
OHU/TOHU -·
4A/4B/4C
ITU/5B/5C
6A/6B/6C
7AI7Bnc

IV Room
Main Phannacy
Clinical Phannacy Office

Phone#
8879
8886
8884

Beeper#

)

Hours
24 hrs
24 hrs

UBP
UBP
UBP
UBP
UBP
UBP
UBP

0281
0258
0246
0273
0229
0213

M-F: 7:30am-10:00pm
M-F: 7:30am-4:00pm
_M-:f: 7:30am-4:00pm
M-F: 7:30am-4:00pm
M-F: 7:30am-10:00pm
M- F: 7:30am-10:00pm
M-F: 7:30am-10:00pm

Main Pharmacy

2250

M-F :7:00am-10:00pm

NICU
4S Hospice
4TMBU
Adl. Psych
6N
6S
IV Room
TSU (UB)

2342
2331
7725
2766
2788
2347
2744
3300

4738

Multi-Purpose Area JDMCC

Outpatient Chemo

0667

1164

Health Spectrum Pharmacy

Employee Prescription

8444

_98.89

17th & Chew Pharmacy

M-F: 7:30am-4:00pm
M-F: 7:30am-5:30pm
Sat: 9:00am-l :OOpm

)

milc\drusinfo.res

)
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